Published in J Am Soc Nephrol on December 01, 2003
Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation (2006) 2.61
Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study. JACC Cardiovasc Imaging (2009) 2.38
Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation (2006) 2.27
Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study. Circulation (2007) 2.23
Urinary creatinine excretion rate and mortality in persons with coronary artery disease: the Heart and Soul Study. Circulation (2010) 1.97
Biomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study. Am J Med (2008) 1.45
The PRIME curriculum. Clinical research training during residency. J Gen Intern Med (2006) 1.43
Fetuin-A and kidney function in persons with coronary artery disease--data from the Heart and Soul Study. Nephrol Dial Transplant (2006) 1.34
Association of cystatin C and estimated GFR with inflammatory biomarkers: the Heart and Soul Study. Nephrol Dial Transplant (2007) 1.27
Cystatin C, left ventricular hypertrophy, and diastolic dysfunction: data from the Heart and Soul Study. J Card Fail (2006) 1.21
Depression, stress, and quality of life in persons with chronic kidney disease: the Heart and Soul Study. Nephron Clin Pract (2005) 1.14
Impact of age and overt proteinuria on outcomes of stage 3 to 5 chronic kidney disease in a referred cohort. Clin J Am Soc Nephrol (2010) 0.98
Lifetime exposure to traumatic psychological stress is associated with elevated inflammation in the Heart and Soul Study. Brain Behav Immun (2012) 0.96
Kidney function and systolic blood pressure new insights from cystatin C: data from the Heart and Soul Study. Am J Hypertens (2006) 0.93
Association of anemia with diastolic dysfunction among patients with coronary artery disease in the Heart and Soul Study. Am J Cardiol (2005) 0.92
Association of kidney function and uncarboxylated matrix Gla protein: data from the Heart and Soul Study. Nephrol Dial Transplant (2009) 0.88
Myocardial revascularization in dyalitic patients: in-hospital period evaluation. Arq Bras Cardiol (2014) 0.84
Urine calcium excretion, cardiovascular events, and mortality in outpatients with stable coronary artery disease (from the Heart and Soul study). Am J Cardiol (2012) 0.80
Contrast-induced nephropathy in patients undergoing percutaneous coronary intervention. Cardiol Res Pract (2010) 0.80
N-terminal pro-B-type natriuretic peptide as a diagnostic test for ventricular dysfunction in patients with coronary disease: data from the heart and soul study. Arch Intern Med (2007) 0.79
How do We Manage Coronary Artery Disease in Patients with CKD and ESRD? Electrolyte Blood Press (2014) 0.78
Current posttraumatic stress disorder and exaggerated threat sensitivity associated with elevated inflammation in the Mind Your Heart Study. Brain Behav Immun (2016) 0.77
Relation of body mass index to urinary creatinine excretion rate in patients with coronary heart disease. Am J Cardiol (2011) 0.77
Associations of N-terminal pro-B-type natriuretic peptide with kidney function decline in persons without clinical heart failure in the Heart and Soul Study. Am Heart J (2014) 0.75
Post-Hoc Study: Intravenous Hydration Treatment in Chinese Patients with High Risk of Contrast-Induced Nephropathy Following Percutaneous Coronary Intervention. Sci Rep (2017) 0.75
Cystatin C is associated with risk of venous thromboembolism in subjects with normal kidney function--the Tromsø study. Haematologica (2012) 0.75
Cystatin C in Acute Coronary Syndrome. EJIFCC (2013) 0.75
Prevalence of Chronic Kidney Disease and the Incidence of Acute Kidney Injury in Patients with Coronary Artery Disease in Mumbai, India. Heart Views (2015) 0.75
Impact of Chronic Kidney Insufficiency on Cardiovascular Outcomes in Patients that Undergo Coronary Revascularization: A Historical Review. ASEAN Heart J (2016) 0.75
Analysis of the Use of Extracorporeal Circulation on the In-Hospital Outcomes of Dialytic Patients Who Underwent Myocardial Revascularization Surgery. Arq Bras Cardiol (2016) 0.75
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62
C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med (2000) 18.04
Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann Intern Med (2001) 6.38
Prevalence of low glomerular filtration rate in nondiabetic Americans: Third National Health and Nutrition Examination Survey (NHANES III). J Am Soc Nephrol (2002) 4.52
Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann Intern Med (2002) 3.92
Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J Am Soc Nephrol (2002) 3.92
Elevations of inflammatory and procoagulant biomarkers in elderly persons with renal insufficiency. Circulation (2003) 3.76
Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol (2003) 2.83
Proposed cardiovascular risk assessment algorithm using high-sensitivity C-reactive protein and lipid screening. Clin Chem (2001) 2.67
Renal function and intensive lowering of blood pressure in hypertensive participants of the hypertension optimal treatment (HOT) study. J Am Soc Nephrol (2001) 1.94
Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis (2001) 1.57
Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease. J Am Coll Cardiol (2001) 1.56
C-reactive protein and ischemia in users and nonusers of beta-blockers and statins: data from the Heart and Soul Study. Circulation (2003) 1.40
Lipoprotein metabolism and renal failure. Am J Kidney Dis (1993) 1.37
Lipid abnormalities in renal disease. Kidney Int (1991) 1.34
Long-term prognostic value of exercise echocardiography compared with exercise 201Tl, ECG, and clinical variables in patients evaluated for coronary artery disease. Circulation (1998) 1.12
Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int Suppl (1993) 0.98
Safety, feasibility, and prognostic implications of pharmacologic stress echocardiography in 1482 patients evaluated in an ambulatory setting. Am Heart J (2001) 0.91
Prognostic value of exercise echocardiography in patients after coronary artery bypass surgery. Am J Cardiol (2001) 0.90
Lipid and lipoprotein ratios as risk factors of atherosclerosis in patients with chronic renal insufficiency (CRI). Int Urol Nephrol (1999) 0.83
Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr (2010) 13.12
Depressive symptoms and health-related quality of life: the Heart and Soul Study. JAMA (2003) 7.01
Long-term risk of mortality and other adverse outcomes after acute kidney injury: a systematic review and meta-analysis. Am J Kidney Dis (2009) 6.54
Depressive symptoms, health behaviors, and risk of cardiovascular events in patients with coronary heart disease. JAMA (2008) 6.50
New loci associated with kidney function and chronic kidney disease. Nat Genet (2010) 5.58
Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection. J Infect Dis (2010) 5.35
The associations of fibroblast growth factor 23 and uncarboxylated matrix Gla protein with mortality in coronary artery disease: the Heart and Soul Study. Ann Intern Med (2010) 4.89
American Society of Echocardiography recommendations for use of echocardiography in clinical trials. J Am Soc Echocardiogr (2004) 4.88
Multiple loci associated with indices of renal function and chronic kidney disease. Nat Genet (2009) 4.78
The relative safety of ephedra compared with other herbal products. Ann Intern Med (2003) 4.65
Cystatin C concentration as a risk factor for heart failure in older adults. Ann Intern Med (2005) 4.57
Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol (2003) 4.28
Cystatin C identifies chronic kidney disease patients at higher risk for complications. J Am Soc Nephrol (2010) 3.85
Renal impairment and outcomes in heart failure: systematic review and meta-analysis. J Am Coll Cardiol (2006) 3.85
Depression screening and patient outcomes in cardiovascular care: a systematic review. JAMA (2008) 3.55
Rapid kidney function decline and mortality risk in older adults. Arch Intern Med (2008) 3.54
Postoperative biomarkers predict acute kidney injury and poor outcomes after adult cardiac surgery. J Am Soc Nephrol (2011) 3.53
Six-minute walk test as a prognostic tool in stable coronary heart disease: data from the heart and soul study. Arch Intern Med (2012) 3.50
Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure: the Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation (2006) 3.31
Kidney function as a predictor of noncardiovascular mortality. J Am Soc Nephrol (2005) 3.28
Renal function and risk of hip and vertebral fractures in older women. Arch Intern Med (2007) 3.27
A prospective study of anemia status, hemoglobin concentration, and mortality in an elderly cohort: the Cardiovascular Health Study. Arch Intern Med (2005) 3.14
Preclinical atherosclerosis due to HIV infection: carotid intima-medial thickness measurements from the FRAM study. AIDS (2009) 3.12
Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc (2002) 3.03
HIV and aging: state of knowledge and areas of critical need for research. A report to the NIH Office of AIDS Research by the HIV and Aging Working Group. J Acquir Immune Defic Syndr (2012) 2.95
Fetuin-A and incident diabetes mellitus in older persons. JAMA (2008) 2.92
Postoperative biomarkers predict acute kidney injury and poor outcomes after pediatric cardiac surgery. J Am Soc Nephrol (2011) 2.90
The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med (2004) 2.86
Noninvasive assessment of pulmonary vascular resistance by Doppler echocardiography. J Am Soc Echocardiogr (2013) 2.83
Renal insufficiency as a predictor of cardiovascular outcomes and mortality in elderly individuals. J Am Coll Cardiol (2003) 2.83
Additive effects of cognitive function and depressive symptoms on mortality in elderly community-living adults. J Gerontol A Biol Sci Med Sci (2003) 2.82
B-type natriuretic peptide and ischemia in patients with stable coronary disease: data from the Heart and Soul study. Circulation (2003) 2.82
Implications of hypertrophic cardiomyopathy transmitted by sperm donation. JAMA (2009) 2.77
Depression and heart rate variability in patients with stable coronary heart disease: findings from the Heart and Soul Study. Arch Gen Psychiatry (2005) 2.73
Cystatin C as a risk factor for outcomes in chronic kidney disease. Ann Intern Med (2007) 2.71
Association between kidney function and albuminuria with cardiovascular events in HIV-infected persons. Circulation (2010) 2.71
CUBN is a gene locus for albuminuria. J Am Soc Nephrol (2011) 2.70
Association of tenofovir exposure with kidney disease risk in HIV infection. AIDS (2012) 2.65
A simple method for noninvasive estimation of pulmonary vascular resistance. J Am Coll Cardiol (2003) 2.62
Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul Study. Circulation (2006) 2.61
Chronic kidney disease associated mortality in diastolic versus systolic heart failure: a propensity matched study. Am J Cardiol (2006) 2.58
Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol (2011) 2.56
Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation (2006) 2.50
Risk factors and secondary prevention in women with heart disease: the Heart and Estrogen/progestin Replacement Study. Ann Intern Med (2003) 2.40
Blood pressure reactivity to psychological stress predicts hypertension in the CARDIA study. Circulation (2004) 2.39
Development of an echocardiographic risk-stratification index to predict heart failure in patients with stable coronary artery disease: the Heart and Soul study. JACC Cardiovasc Imaging (2009) 2.38
Association of a serotonin transporter polymorphism (5-HTTLPR) with depression, perceived stress, and norepinephrine in patients with coronary disease: the Heart and Soul Study. Am J Psychiatry (2007) 2.37
Self-reported medication adherence and cardiovascular events in patients with stable coronary heart disease: the heart and soul study. Arch Intern Med (2007) 2.34
Red cell distribution width and mortality in older adults: a meta-analysis. J Gerontol A Biol Sci Med Sci (2009) 2.32
Vitamin D deficiency and cardiovascular events in patients with coronary heart disease: data from the Heart and Soul Study. Am J Epidemiol (2014) 2.30
Central nervous system active medications and risk for fractures in older women. Arch Intern Med (2003) 2.30
Depression and medication adherence in outpatients with coronary heart disease: findings from the Heart and Soul Study. Arch Intern Med (2005) 2.28
Microalbuminuria in HIV infection. AIDS (2007) 2.28
Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study. Circulation (2006) 2.27
Relationship of uric acid with progression of kidney disease. Am J Kidney Dis (2007) 2.26
Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol (2006) 2.26
Dose-dependent augmentation of cardiac systolic function with the selective cardiac myosin activator, omecamtiv mecarbil: a first-in-man study. Lancet (2011) 2.25
Awareness of kidney disease and relationship to end-stage renal disease and mortality. Am J Med (2012) 2.24
Association of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul Study. Circulation (2007) 2.23
Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study). J Am Coll Cardiol (2012) 2.22
Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol (2008) 2.18
Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study). Am J Cardiol (2005) 2.18
Differences in medical care and disease outcomes among black and white women with heart disease. Circulation (2003) 2.16
Racial and ethnic disparities in mortality from acute lung injury. Crit Care Med (2009) 2.14
Differences in kidney function and incident hypertension: the multi-ethnic study of atherosclerosis. Ann Intern Med (2008) 2.11
Telomere length trajectory and its determinants in persons with coronary artery disease: longitudinal findings from the heart and soul study. PLoS One (2010) 2.10
Associations between kidney function and subclinical cardiac abnormalities in CKD. J Am Soc Nephrol (2012) 2.10
Uromodulin levels associate with a common UMOD variant and risk for incident CKD. J Am Soc Nephrol (2009) 2.10
Biomarkers predict progression of acute kidney injury after cardiac surgery. J Am Soc Nephrol (2012) 2.00
Compensatory changes in atrial volumes with normal aging: is atrial enlargement inevitable? J Am Coll Cardiol (2002) 1.99
Scared to death? Generalized anxiety disorder and cardiovascular events in patients with stable coronary heart disease:The Heart and Soul Study. Arch Gen Psychiatry (2010) 1.99
Association of upper trunk and visceral adipose tissue volume with insulin resistance in control and HIV-infected subjects in the FRAM study. J Acquir Immune Defic Syndr (2007) 1.98
Urinary creatinine excretion rate and mortality in persons with coronary artery disease: the Heart and Soul Study. Circulation (2010) 1.97
Differential associations between specific depressive symptoms and cardiovascular prognosis in patients with stable coronary heart disease. J Am Coll Cardiol (2010) 1.96
Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomes. J Am Soc Nephrol (2013) 1.95
Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study. Arch Intern Med (2007) 1.94
Association of kidney function with incident hip fracture in older adults. J Am Soc Nephrol (2006) 1.92
Control of hypertension in adults with chronic kidney disease in the United States. Hypertension (2005) 1.92
Depressive symptoms, health behaviors, and subsequent inflammation in patients with coronary heart disease: prospective findings from the heart and soul study. Am J Psychiatry (2011) 1.92
Prognostic value of leukocyte telomere length in patients with stable coronary artery disease: data from the Heart and Soul Study. Arterioscler Thromb Vasc Biol (2008) 1.92
Chronic kidney disease and cognitive impairment in menopausal women. Am J Kidney Dis (2005) 1.91
Cystatin C and measures of physical function in elderly adults: the Health, Aging, and Body Composition (HABC) Study. Am J Epidemiol (2006) 1.91
Improving guideline adherence: a randomized trial evaluating strategies to increase beta-blocker use in heart failure. Circulation (2003) 1.89
Early postoperative serum cystatin C predicts severe acute kidney injury following pediatric cardiac surgery. Kidney Int (2011) 1.88
Blood pressure reactivity to psychological stress and coronary calcification in the Coronary Artery Risk Development in Young Adults Study. Hypertension (2006) 1.86
Cystatin C, albuminuria, and 5-year all-cause mortality in HIV-infected persons. Am J Kidney Dis (2010) 1.84